No Data
No Data
No Data
No Data
No Data
We're Not Worried About Castle Biosciences' (NASDAQ:CSTL) Cash Burn
Yahoo FinanceApr 17 07:06 ET
Castle Biosciences(CSTL.US) Officer Sells US$106.02K in Common Stock
$Castle Biosciences(CSTL.US)$ Officer MAETZOLD DEREK J sold 5,210 shares of common stock on Apr 12, 2024 at an average price of $20.35 for a total value of $106.02K.Source: Announcement What is statem
moomoo NewsApr 16 17:29 ET
Form 144 | Castle Biosciences(CSTL.US) Officer Proposes to Sell 381.3K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 12, $Castle Biosciences(CSTL.US)$ Officer Derek Maetzold intends to sell 19,008 shares of its common stock on Apr 12, with a total market value of approximately $381.3K.
moomoo NewsApr 12 16:40 ET
Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024
Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the first quarter ended March 31, 2024,
BusinesswireApr 11 07:00 ET
Castle Biosciences(CSTL.US) Director Sells US$49,087.2 in Common Stock
$Castle Biosciences(CSTL.US)$ Director BRADBURY DANIEL sold 2,400 shares of common stock on Apr 8, 2024 at an average price of $20.453 for a total value of $49,087.2.Source: Announcement What is state
moomoo NewsApr 10 17:16 ET
Castle Biosciences Celebrates Esophageal Cancer Awareness Month Through Advocacy and Educational Collaborations
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, recognizes the importance of Esophageal Cancer Awareness Month and is providing its support of key programs and initiatives throughout the month of April.
BusinesswireApr 10 17:00 ET
No Data
No Data